CATALYST is a leading health outcomes research consultancy that has built its international reputation by conducting high-quality, scientifically rigorous studies.
CATALYST has a committed core team of health economists and research analysts with, collectively, more than 40 years’ international experience of the healthcare industry and health outcomes sector. Our multi-disciplinary team use this wealth of experience gained in the pharmaceutical industry, academia and health services worldwide to provide its clients with a comprehensive range of services related to health outcomes research.
Led by Professor Julian Guest, founder and managing director, the CATALYST team can apply a range of personal skills and capabilities to specific clients’ projects. Not only does this ensure flexibility, personal attention to detail and ownership of individual projects, but it also guarantees commitment to achieving our clients’ objectives.
About Professor Julian Guest
Julian Guest has a PhD in molecular neurobiology and a diploma in marketing. After obtaining his doctorate from The Institute of Neurology, London University, Julian continued with genetic research prior to joining the pharmaceutical industry to conduct international clinical trials. From clinical trials, Julian moved into marketing and health economics and, in 1991, established CATALYST. Under Julian’s direction, CATALYST has undertaken numerous international health outcomes research projects in diverse therapeutic areas in Europe, North and South America, South Africa, the Middle East, Far East and Australasia. Julian has published extensively in the field of pharmacoeconomics in relation to these different therapeutic areas and presented at numerous international conferences. In September 2005, Julian was appointed Visiting Professor of Health Economics at the Postgraduate Medical School, University of Surrey and in September 2010 he was appointed Visiting Professor of Health Economics at the School of Biomedical Sciences, King’s College, London.